Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Kras
    (4)
  • Ras
    (4)
  • Transferase
    (2)
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • Raf
    (1)
  • Others
    (2)
Filter
Search Result
Results for "

k-ras-4b

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    5
    TargetMol | All_Pathways
  • Recombinant Protein
    55
    TargetMol | Recombinant_Protein
  • Antibody Products
    1
    TargetMol | Antibody_Products
KRAS4b-IN-D14
T71717924249-06-9
KRAS4b-IN-D14 is a specific inhibitor of oncogenic KRAS4b signaling which stabilizes the KRAS4b-PDEδ complex and remarkably decreases tumor size and triggered apoptosis of tumor cells.
  • $1,520
6-8 weeks
Size
QTY
Kras4B G12D-IN-1
T781702042365-85-3
Kras4B G12D-IN-1 is an anticancer agent that functions as an inhibitor of the Kras4B G12D protein. It effectively reduces the expression of Kras protein in mouse embryonic fibroblasts (MEFs) harboring the Kras4B G12D mutation[1].
  • $89
In Stock
Size
QTY
LB42708
T2678226929-39-1In house
LB42708 is an orally active farnesyltransferase (FTase) inhibitor (IC50: 0.8/1.2/2.0 nM toward H/N/K-ras).
  • $34
In Stock
Size
QTY
Lonafarnib
Sch66336, Sarasar
T6302193275-84-2
Lonafarnib (Sch66336) is an orally bioavailable FPTase inhibitor for H-ras, K-ras-4B, and N-ras (IC50: 1.9/5.2/2.8 nM).
  • $41
In Stock
Size
QTY
TargetMol | Citations Cited
KRAS4b-PDEδ stabilizer C19
T324191049727-35-6
KRAS4b-PDEδ stabilizer C19 is a stabilizer of the KRAS4b-PDEδ complex which decreases the proliferation of colorectal cancer cells, and increases apoptosis via decreased activation of oncogenic KRAS4b signaling.
  • $1,520
6-8 weeks
Size
QTY